Jonathan Friedberg
MD MMSc
Director, Wilmot Cancer Institute
👥Biography 个人简介
Jonathan Friedberg at Rochester leads a major lymphoma clinical research program and has contributed to cooperative group DLBCL trials, including evaluations of ibrutinib in ABC-DLBCL and lenalidomide-R-CHOP in first-line DLBCL. His work on subtype-specific DLBCL therapy and his leadership in North American lymphoma cooperative group trials have been significant.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jonathan Friedberg 的研究动态
Follow Jonathan Friedberg's research updates
留下邮箱，当我们发布与 Jonathan Friedberg（University of Rochester）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment